These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38227598)

  • 1. Longitudinal MRI and 1H-MRS study of SCA7 mouse forebrain reveals progressive multiregional atrophy and early brain metabolite changes indicating early neuronal and glial dysfunction.
    Pérot JB; Niewiadomska-Cimicka A; Brouillet E; Trottier Y; Flament J
    PLoS One; 2024; 19(1):e0296790. PubMed ID: 38227598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2.
    Niewiadomska-Cimicka A; Doussau F; Perot JB; Roux MJ; Keime C; Hache A; Piguet F; Novati A; Weber C; Yalcin B; Meziane H; Champy MF; Grandgirard E; Karam A; Messaddeq N; Eisenmann A; Brouillet E; Nguyen HHP; Flament J; Isope P; Trottier Y
    J Neurosci; 2021 Jun; 41(22):4910-4936. PubMed ID: 33888607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
    Niewiadomska-Cimicka A; Trottier Y
    Neurotherapeutics; 2019 Oct; 16(4):1074-1096. PubMed ID: 31432449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteins.
    Alves S; Marais T; Biferi MG; Furling D; Marinello M; El Hachimi K; Cartier N; Ruberg M; Stevanin G; Brice A; Barkats M; Sittler A
    Mol Neurodegener; 2016 Jul; 11(1):58. PubMed ID: 27465358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 Carriers.
    Coarelli G; Dubec-Fleury C; Petit E; Sayah S; Fischer C; Nassisi M; Gatignol P; Dorgham K; Daghsen L; Daye P; Cunha P; Kacher R; Hilab R; Hurmic H; Lamazière A; Lamy JC; Welter ML; Chupin M; Mangin JF; Lane R; Gaymard B; Pouget P; Audo I; Brice A; Tezenas du Montcel S; Durr A
    Neurology; 2024 Sep; 103(5):e209749. PubMed ID: 39133883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of senescence observed in spinocerebellar ataxia type 7 mouse model.
    Miller W; Pruett CLH; Stone W; Eide C; Riddle M; Popp C; Yousefzadeh M; Lees C; Seelig D; Thompson E; Orr H; Niedernhofer L; Tolar J
    PLoS One; 2022; 17(10):e0275580. PubMed ID: 36251631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive degeneration in a new Drosophila model of spinocerebellar ataxia type 7.
    Sujkowski A; Ranxhi B; Bangash ZR; Chbihi ZM; Prifti MV; Qadri Z; Alam N; Todi SV; Tsou WL
    Sci Rep; 2024 Jun; 14(1):14332. PubMed ID: 38906973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
    Furrer SA; Mohanachandran MS; Waldherr SM; Chang C; Damian VA; Sopher BL; Garden GA; La Spada AR
    J Neurosci; 2011 Nov; 31(45):16269-78. PubMed ID: 22072678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First families with spinocerebellar ataxia type 7 in Poland.
    Dulski J; Al-Shaikh RH; Prudencio M; Petrucelli L; Sulek A; Bernatowicz K; Sławek J; Wszolek ZK
    Neurol Neurochir Pol; 2023; 57(3):310-313. PubMed ID: 37283503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Analysis of the Relation Between Clinical Impairment and Gray Matter Degeneration in Spinocerebellar Ataxia Type 7 Patients.
    Contreras A; Ramirez-Garcia G; Chirino A; Morgado-Valle C; Pasaye EH; Hernandez-Castillo C; Díaz R; Fernandez-Ruiz J; Beltran-Parrazal L
    Cerebellum; 2021 Jun; 20(3):346-360. PubMed ID: 33184781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice.
    Chort A; Alves S; Marinello M; Dufresnois B; Dornbierer JG; Tesson C; Latouche M; Baker DP; Barkats M; El Hachimi KH; Ruberg M; Janer A; Stevanin G; Brice A; Sittler A
    Brain; 2013 Jun; 136(Pt 6):1732-45. PubMed ID: 23518714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7.
    Fusco AF; Pucci LA; Switonski PM; Biswas DD; McCall AL; Kahn AF; Dhindsa JS; Strickland LM; La Spada AR; ElMallah MK
    Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34160002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
    Karam A; Trottier Y
    Adv Exp Med Biol; 2018; 1049():197-218. PubMed ID: 29427104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinocerebellar ataxia Type 7: clinical and genetic study of a new Moroccan family (case report).
    Bouzid FZ; Mansouri M; Abdelaziz C; Louhab N; Bernard S; Strubi-Vuillaume I; Dafir K; Aboussair N
    Pan Afr Med J; 2021; 38():162. PubMed ID: 33995769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice.
    Alves S; Cormier-Dequaire F; Marinello M; Marais T; Muriel MP; Beaumatin F; Charbonnier-Beaupel F; Tahiri K; Seilhean D; El Hachimi K; Ruberg M; Stevanin G; Barkats M; den Dunnen W; Priault M; Brice A; Durr A; Corvol JC; Sittler A
    Acta Neuropathol; 2014 Nov; 128(5):705-22. PubMed ID: 24859968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family.
    Martin J; Van Regemorter N; Del-Favero J; Löfgren A; Van Broeckhoven C
    J Neurol Sci; 1999 Sep; 168(1):37-46. PubMed ID: 10500272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinocerebellar ataxia 7 (SCA7).
    Lebre AS; Brice A
    Cytogenet Genome Res; 2003; 100(1-4):154-63. PubMed ID: 14526176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.
    Niu C; Prakash TP; Kim A; Quach JL; Huryn LA; Yang Y; Lopez E; Jazayeri A; Hung G; Sopher BL; Brooks BP; Swayze EE; Bennett CF; La Spada AR
    Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models.
    Marinello M; Werner A; Giannone M; Tahiri K; Alves S; Tesson C; den Dunnen W; Seeler JS; Brice A; Sittler A
    Dis Model Mech; 2019 Jan; 12(1):. PubMed ID: 30559154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
    Garden GA; La Spada AR
    Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.